ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Wize Pharma, Inc."
Episode Synopsis
Wize Pharma (OTCQB: WIZPD) is a clinical-stage biopharmaceutical company currently focused on the treatment of ophthalmic disorders, including Dry Eye Syndrome. Wize Pharma has inlicensed certain rights to purchase, market, sell and distribute a formula known as LO2A, a drug developed for the treatment of Dry Eye Syndrome, and other ophthalmological illnesses, including Sjorgen's Syndrome and Conjunctivochalasis.
More episodes of the podcast OTCQB Podcast
Cytta Corp.
12/01/2026
DarkPulse, Inc.
05/01/2026
Q2 Metals Corp.
08/12/2025
Zoomcar Holdings, Inc.
01/12/2025
Scorpio Gold Corp.
24/11/2025
Stuhini Exploration Ltd.
17/11/2025
Dotz Nano Ltd.
10/11/2025
District Metals Corp.
03/11/2025
Banyan Gold Corp.
27/10/2025
Brixton Metals Corp.
20/10/2025
In God we trust